"EasteAdvantage Assurance Company","PNC AS","2024 03 31" Annual Statutory Statement
QUARTERLY STATEMENT
OF THE
EASTERN ADVANTAGE ASSURANCE COMPANY
TO THE
OF THE
STATE OF
FOR THE QUARTER ENDED
PROPERTY AND CASUALTY
2024
STATEMENT AS OF
ASSETS
|
Current Statement Date |
4 |
|||||
|
1 |
2 |
3 |
|
|||
|
Net Admitted Assets |
Prior Year Net |
|||||
|
Assets |
Nonadmitted Assets |
(Cols. 1 - 2) |
Admitted Assets |
|||
|
1. |
Bonds |
................. 29,594,860 |
................................... |
................. |
29,594,860 |
................. 28,723,320 |
|
2. |
Stocks: |
|||||
|
2.1 Preferred stocks |
................................... |
................................... |
................................. |
0 |
.................................0 |
|
|
2.2 Common stocks |
................................... |
................................... |
................................. |
0 |
.................................0 |
3. Mortgage loans on real estate:
|
3.1 First liens |
................................... |
................................... |
0 |
0 |
||||
|
3.2 Other than first liens |
................................... |
................................... |
0 |
0 |
||||
|
4. |
Real estate: |
|||||||
|
4.1 Properties occupied by the company (less $ |
||||||||
|
encumbrances) |
................................... |
................................... |
0 |
0 |
||||
|
4.2 Properties held for |
the production of income (less |
|||||||
|
$ |
encumbrances) |
................................... |
................................... |
.................................0 |
.................................0 |
|||
|
4.3 Properties held for sale (less $ |
||||||||
|
.......................................................................................encumbrances) |
................................... |
................................... |
.................................0 |
.................................0 |
||||
|
5. |
Cash ($ |
10,403 ), cash equivalents |
||||||
|
($ |
119,606 |
) and short-term |
||||||
|
investments ($ |
................................. |
0 ) |
130,009 |
................................... |
130,009 |
1,066,915 |
||
|
6. |
Contract loans (including $ |
................................... premium notes) |
................................... |
................................... |
0 |
0 |
||
|
7. |
Derivatives |
................................... |
................................... |
0 |
0 |
|||
|
8. |
Other invested assets |
................................... |
................................... |
0 |
0 |
|||
|
9. |
Receivables for securities |
................................... |
................................... |
0 |
30,000 |
|||
|
10. |
Securities lending reinvested collateral assets |
................................... |
................................... |
0 |
0 |
|||
|
11. |
Aggregate write-ins for invested assets |
0 |
0 |
0 |
0 |
|||
|
12. |
Subtotals, cash and invested assets (Lines 1 to 11) |
29,724,869 |
0 |
29,724,869 |
29,820,235 |
|||
|
13. |
Title plants less $ |
charged off (for Title insurers |
||||||
|
only) |
................................... |
................................... |
0 |
0 |
||||
|
14. |
Investment income due and accrued |
163,631 |
................................... |
163,631 |
188,468 |
15. Premiums and considerations:
|
15.1 |
Uncollected premiums and agents' balances in the course of collection |
1,823,322 |
39,638 |
1,783,684 |
491,767 |
|
|
15.2 |
Deferred premiums, agents' balances and installments booked but |
|||||
|
deferred and not yet due (including $ |
.......................793,000 |
|||||
|
earned but unbilled premiums) |
32,477,997 |
79,300 |
32,398,697 |
29,966,618 |
||
|
15.3 |
Accrued retrospective premiums ($ |
) and |
||||
|
contracts subject to redetermination ($ |
................................... ) |
................................... |
................................... |
.................................0 |
0 |
16. Reinsurance:
|
16.1 |
....................................................Amounts recoverable from reinsurers |
................................... |
................................... |
.................................0 |
.................................0 |
|
|
16.2 |
Funds held by or deposited with reinsured companies |
................................... |
................................... |
.................................0 |
.................................0 |
|
|
16.3 |
Other amounts receivable under reinsurance contracts |
................................... |
................................... |
.................................0 |
.................................0 |
|
|
17. |
Amounts receivable relating to uninsured plans |
................................... |
................................... |
.................................0 |
.................................0 |
|
|
18.1 |
....Current federal and foreign income tax recoverable and interest thereon |
.......................589,473 |
................................... |
.......................589,473 |
...................... 557,844 |
|
|
18.2 |
Net deferred tax asset |
................................................................................... |
.......................867,354 |
..........................4,936 |
...................... 862,418 |
...................... 819,195 |
|
19. |
Guaranty funds receivable or on deposit |
................................... |
................................... |
.................................0 |
.................................0 |
|
|
20. |
Electronic data processing equipment and software |
................................... |
................................... |
.................................0 |
.................................0 |
|
|
21. |
Furniture and equipment, including health care delivery assets |
|||||
|
...................................($ |
................................... |
................................... |
.................................0 |
.................................0 |
||
|
22. |
.........Net adjustment in assets and liabilities due to foreign exchange rates |
................................... |
................................... |
.................................0 |
.................................0 |
|
|
23. |
Receivables from parent, subsidiaries and affiliates |
................... 8,889,759 |
................................... |
................... 8,889,759 |
................... 7,321,691 |
|
|
24. |
Health care ($ |
) and other amounts receivable |
................................... |
................................... |
.................................0 |
.................................0 |
|
25. |
Aggregate write-ins for other than invested assets |
...................... 664,364 |
.................................0 |
...................... 664,364 |
.......................593,787 |
26. Total assets excluding Separate Accounts, Segregated Accounts and
|
Protected Cell Accounts (Lines 12 to 25) |
75,200,769 |
123,874 |
75,076,895 |
69,759,605 |
|
|
27. |
From Separate Accounts, Segregated Accounts and Protected Cell |
||||
|
Accounts |
................................... |
................................... |
.................................0 |
.................................0 |
|
|
28. |
Total (Lines 26 and 27) |
75,200,769 |
123,874 |
75,076,895 |
69,759,605 |
|
DETAILS OF WRITE-INS |
|||||
|
1101. |
...................................................................................................................... |
.................................... |
.................................... |
.................................... |
.................................... |
|
1102. |
...................................................................................................................... |
.................................... |
.................................... |
.................................... |
.................................... |
|
1103. |
...................................................................................................................... |
.................................... |
.................................... |
.................................... |
.................................... |
|
1198. |
Summary of remaining write-ins for Line 11 from overflow page |
.................................0 |
.................................0 |
.................................0 |
.................................0 |
|
1199. |
Totals (Lines 1101 through 1103 plus 1198)(Line 11 above) |
0 |
0 |
0 |
0 |
|
2501. |
Excise tax receivable |
................................... |
................................... |
.................................0 |
.................................0 |
|
2502. |
State premium tax receivable |
||||
|
...................... 664,364 |
................................... |
...................... 664,364 |
.......................593,787 |
||
|
2503. |
....................................................................................................................... |
.................................... |
.................................... |
.................................... |
.................................... |
|
2598. |
Summary of remaining write-ins for Line 25 from overflow page |
.................................0 |
.................................0 |
.................................0 |
.................................0 |
|
2599. |
Totals (Lines 2501 through 2503 plus 2598)(Line 25 above) |
664,364 |
0 |
664,364 |
593,787 |
2
STATEMENT AS OF
LIABILITIES, SURPLUS AND OTHER FUNDS
|
1 |
2 |
|||||||
|
Current |
|
|||||||
|
Statement Date |
Prior Year |
|||||||
|
1. |
Losses (current accident year $ |
3,371,298 ) |
................. 15,730,266 |
................. 16,398,297 |
||||
|
2. |
.......................................................................................Reinsurance payable on paid losses and loss adjustment expenses |
................... 8,193,120 |
................... 7,904,162 |
|||||
|
3. |
Loss adjustment expenses |
................... 2,524,557 |
................... 2,320,217 |
|||||
|
4. |
Commissions payable, contingent commissions and other similar charges |
............................................................................. |
...................... 720,559 |
.......................585,734 |
||||
|
5. |
...............................................................................................................Other expenses (excluding taxes, licenses and fees) |
........................ 35,163 |
................................... |
|||||
|
6. |
...................................................................................Taxes, licenses and fees (excluding federal and foreign income taxes) |
........................ 49,118 |
...................... 429,106 |
|||||
|
7.1 |
Current federal and foreign income taxes (including $ |
on realized capital gains (losses)) |
.............. |
................................... |
................................... |
|||
|
7.2 |
Net deferred tax liability |
................................... |
................................... |
|||||
|
8. |
Borrowed money $ |
and interest thereon $ |
.............................................. |
................................... |
................................... |
|||
|
9. |
Unearned premiums (after deducting unearned premiums for ceded reinsurance of $ |
19,824,437 |
and |
|||||
|
including warranty reserves of $ ................................... and accrued accident and health experience rating refunds |
||||||||
|
including $ |
0 |
...............................for medical loss ratio rebate per the Public Health Service Act) |
................. 10,043,497 |
................... 8,832,486 |
||||
|
10. |
Advance premium |
........................ 61,576 |
...................... 291,030 |
|||||
|
11. |
Dividends declared and unpaid: |
|||||||
|
11.1 Stockholders |
................................... |
................................... |
||||||
|
11.2 Policyholders |
........................ 21,301 |
........................ 11,439 |
||||||
|
12. |
........................................................................................Ceded reinsurance premiums payable (net of ceding commissions) |
................. 24,168,422 |
................. 19,044,000 |
|||||
|
13. |
..................................................................................................................Funds held by company under reinsurance treaties |
................................... |
.................................0 |
|||||
|
14. |
..............................................................................................Amounts withheld or retained by company for account of others |
.......................727,386 |
...................... 884,728 |
|||||
|
15. |
........................................................................................................................................Remittances and items not allocated |
.......................135,756 |
........................ 90,953 |
|||||
|
16. |
Provision for reinsurance (including $ |
................................... certified) |
.......................177,000 |
.......................177,000 |
||||
|
17. |
...................................................................................Net adjustments in assets and liabilities due to foreign exchange rates |
................................... |
................................... |
|||||
|
18. |
Drafts outstanding |
................................... |
................................... |
|||||
|
19. |
............................................................................................................................Payable to parent, subsidiaries and affiliates |
................................... |
................................... |
|||||
|
20. |
Derivatives |
.................................0 |
.................................0 |
|||||
|
21. |
Payable for securities |
................................... |
................................... |
|||||
|
22. |
....................................................................................................................................................Payable for securities lending |
................................... |
................................... |
|||||
|
23. |
......................................................................................................................Liability for amounts held under uninsured plans |
................................... |
................................... |
|||||
|
24. |
Capital notes $ |
and interest thereon $ |
................................................. |
................................... |
................................... |
|||
|
25. |
Aggregate write-ins for liabilities |
0 |
0 |
|||||
|
26. |
Total liabilities excluding protected cell liabilities (Lines 1 through 25) |
62,587,721 |
56,969,152 |
|||||
|
27. |
Protected cell liabilities |
................................... |
................................... |
|||||
|
28. |
...............................................................................................................................................Total liabilities (Lines 26 and 27) |
................. 62,587,721 |
................. 56,969,152 |
|||||
|
29. |
............................................................................................................................Aggregate write-ins for special surplus funds |
.................................0 |
.................................0 |
|||||
|
30. |
Common capital stock |
...................2,501,250 |
...................2,501,250 |
|||||
|
31. |
Preferred capital stock |
................................... |
................................... |
|||||
|
32. |
Aggregate write-ins for other than special surplus funds |
.................................0 |
.................................0 |
|||||
|
33. |
Surplus notes |
................................... |
................................... |
|||||
|
34. |
.......................................................................................................................................Gross paid in and contributed surplus |
................... 5,898,750 |
................... 5,898,750 |
|||||
|
35. |
Unassigned funds (surplus) |
................... 4,089,174 |
................... 4,390,453 |
|||||
|
36. |
Less treasury stock, at cost: |
|||||||
|
36.1 |
shares common (value included in Line 30 |
$ |
) |
................................... |
................................... |
|||
|
36.2 |
shares preferred (value included in Line 31 |
$ |
) |
|||||
|
37. |
Surplus as regards policyholders (Lines 29 to 35, less 36) |
12,489,174 |
12,790,453 |
|||||
|
38. |
Totals (Page 2, Line 28, Col. 3) |
75,076,895 |
69,759,605 |
|||||
|
DETAILS OF WRITE-INS |
||||||||
|
2501 |
.................................... |
|||||||
|
2502 |
.................................... |
|||||||
|
2503 |
.................................... |
|||||||
|
2598. |
..............................................................................................Summary of remaining write-ins for Line 25 from overflow page |
.................................0 |
.................................0 |
|||||
|
2599. |
Totals (Lines 2501 through 2503 plus 2598)(Line 25 above) |
0 |
0 |
|||||
|
2901 |
.................................... |
|||||||
|
2902 |
.................................... |
|||||||
|
2903 |
.................................... |
|||||||
|
2998. |
..............................................................................................Summary of remaining write-ins for Line 29 from overflow page |
.................................0 |
.................................0 |
|||||
|
2999. |
Totals (Lines 2901 through 2903 plus 2998)(Line 29 above) |
0 |
0 |
|||||
|
3201 |
.................................... |
|||||||
|
3202 |
.................................... |
|||||||
|
3203 |
.................................... |
|||||||
|
3298. |
..............................................................................................Summary of remaining write-ins for Line 32 from overflow page |
.................................0 |
.................................0 |
|||||
|
3299. |
Totals (Lines 3201 through 3203 plus 3298)(Line 32 above) |
0 |
0 |
3
STATEMENT AS OF
STATEMENT OF INCOME
|
1 |
2 |
3 |
|||||
|
Current |
Prior Year |
Prior Year Ended |
|||||
|
Year to Date |
to Date |
|
|||||
|
UNDERWRITING INCOME |
|||||||
|
1. |
Premiums earned: |
||||||
|
1.1 Direct (written $ |
12,086,534 |
) |
...................9,429,048 |
...................8,802,005 |
................. 35,660,114 |
||
|
1.2 Assumed (written $ |
.............................................................................9,332,604 ) |
................... 7,884,883 |
................... 7,689,487 |
................. 31,093,757 |
|||
|
1.3 Ceded (written $ |
14,969,705 |
) |
................. 12,075,508 |
................. 11,309,632 |
................. 46,377,119 |
||
|
1.4 Net (written $ |
6,449,433 ) |
..................................................................................... |
................... 5,238,423 |
...................5,181,860 |
................. 20,376,752 |
||
|
DEDUCTIONS: |
|||||||
|
2. |
Losses incurred (current accident year $ |
4,096,370 |
): |
||||
|
2.1 Direct |
6,432,845 |
5,848,402 |
................. 26,901,906 |
||||
|
2.2 Assumed |
4,348,662 |
4,191,697 |
................. 19,494,974 |
||||
|
2.3 Ceded |
................... 7,151,916 |
................... 6,510,853 |
................. 31,023,412 |
||||
|
2.4 Net |
................... 3,629,591 |
................... 3,529,246 |
................. 15,373,468 |
||||
|
3. |
....................................................................................................Loss adjustment expenses incurred |
.......................403,287 |
.......................392,135 |
................... 2,399,605 |
|||
|
4. |
.................................................................................................Other underwriting expenses incurred |
................... 1,726,769 |
...................1,469,454 |
................... 6,152,769 |
|||
|
5. |
Aggregate write-ins for underwriting deductions |
||||||
|
0 |
0 |
.................................0 |
|||||
|
6. |
Total underwriting deductions (Lines 2 through 5) |
5,759,647 |
5,390,835 |
................. 23,925,842 |
|||
|
7. |
.............................................................................................................Net income of protected cells |
||||||
|
8. |
Net underwriting gain (loss) (Line 1 minus Line 6 + Line 7) |
(521,224) |
(208,975) |
................. (3,549,090) |
|||
|
INVESTMENT INCOME |
|||||||
|
9. |
Net investment income earned |
216,921 |
194,040 |
...................... 821,120 |
|||
|
10. |
Net realized capital gains (losses) less capital gains tax of $ |
(86) |
85 |
(126,039) |
(79,340) |
||
|
11. |
Net investment gain (loss) (Lines 9 + 10) |
217,006 |
68,001 |
.......................741,780 |
|||
|
OTHER INCOME |
|||||||
|
12. |
Net gain or (loss) from agents' or premium balances charged off (amount recovered |
||||||
|
$ |
amount charged off $ |
8,324 ) |
........................ (8,324) |
.......................(15,762) |
.......................(37,590) |
||
|
13. |
Finance and service charges not included in premiums |
8,039 |
14,200 |
48,099 |
|||
|
14. |
Aggregate write-ins for miscellaneous income |
................................................................................... |
0 |
0 |
0 |
||
|
15. |
Total other income (Lines 12 through 14) |
(285) |
(1,562) |
10,509 |
16. Net income before dividends to policyholders, after capital gains tax and before all other federal
|
and foreign income taxes (Lines 8 + 11 + 15) |
(304,503) |
(142,536) |
(2,796,801) |
|
17. Dividends to policyholders |
41,117 |
58,009 |
159,078 |
18. Net income, after dividends to policyholders, after capital gains tax and before all other federal and
|
foreign income taxes (Line 16 minus Line 17) |
(345,620) |
(200,545) |
(2,955,879) |
||
|
19. |
Federal and foreign income taxes incurred |
(31,543) |
(762) |
(518,374) |
|
|
20. |
Net income (Line 18 minus Line 19)(to Line 22) |
(314,077) |
(199,783) |
(2,437,505) |
|
|
CAPITAL AND SURPLUS ACCOUNT |
|||||
|
21. |
Surplus as regards policyholders, |
12,790,452 |
17,048,981 |
17,048,981 |
|
|
22. |
Net income (from Line 20) |
(314,077) |
(199,783) |
(2,437,505) |
|
|
23. |
Net transfers (to) from Protected Cell accounts |
................................... |
................................... |
................................... |
|
|
24. |
Change in net unrealized capital gains (losses) less capital gains tax of $ |
................................... |
............................(239) |
.......................... 3,774 |
|
|
25. |
Change in net unrealized foreign exchange capital gain (loss) |
................................... |
................................... |
................................... |
|
|
26. |
Change in net deferred income tax |
........................ 47,542 |
...................... (26,110) |
........................ 92,961 |
|
|
27. |
Change in nonadmitted assets |
||||
|
.......................(34,743) |
...................... (11,462) |
.......................(35,861) |
|||
|
28. |
Change in provision for reinsurance |
................................... |
................................... |
.....................(177,000) |
|
|
29. |
Change in surplus notes |
................................... |
................................... |
................................... |
|
|
30. |
Surplus (contributed to) withdrawn from protected cells |
................................... |
................................... |
................................... |
|
|
31. |
Cumulative effect of changes in accounting principles |
................................... |
................................... |
................................... |
|
|
32. |
Capital changes: |
||||
|
32.1 Paid in |
................................... |
................................... |
................................... |
||
|
32.2 Transferred from surplus (Stock Dividend) |
................................... |
................................... |
................................... |
||
|
32.3 Transferred to surplus |
................................... |
................................... |
................................... |
||
|
33. |
Surplus adjustments: |
||||
|
33.1 Paid in |
.................................0 |
.................................0 |
.................................0 |
||
|
33.2 Transferred to capital (Stock Dividend) |
|||||
|
................................... |
................................... |
................................... |
|||
|
33.3 Transferred from capital |
................................... |
................................... |
................................... |
||
|
34. |
Net remittances from or (to) Home Office |
................................... |
................................... |
................................... |
|
|
35. |
Dividends to stockholders |
................................... |
................................... |
................. (1,704,898) |
|
|
36. |
Change in treasury stock |
................................... |
................................... |
.................................0 |
|
|
37. |
Aggregate write-ins for gains and losses in surplus |
0 |
0 |
0 |
|
|
38. |
Change in surplus as regards policyholders (Lines 22 through 37) |
(301,278) |
(237,594) |
(4,258,529) |
|
|
39. |
Surplus as regards policyholders, as of statement date (Lines 21 plus 38) |
12,489,174 |
16,811,387 |
12,790,452 |
|
|
DETAILS OF WRITE-INS |
|||||
|
0501 |
.................................... |
.................................... |
.................................... |
||
|
0502 |
.................................... |
.................................... |
.................................... |
||
|
0503 |
.................................... |
.................................... |
.................................... |
||
|
0598. |
Summary of remaining write-ins for Line 5 from overflow page |
0 |
0 |
.................................0 |
|
|
0599. |
Totals (Lines 0501 through 0503 plus 0598)(Line 5 above) |
0 |
0 |
0 |
|
|
1401 |
.................................... |
.................................... |
.................................... |
||
|
1402 |
.................................... |
.................................... |
.................................... |
||
|
1403 |
.................................... |
.................................... |
.................................... |
||
|
1498. |
Summary of remaining write-ins for Line 14 from overflow page |
.................................0 |
.................................0 |
.................................0 |
|
|
1499. |
Totals (Lines 1401 through 1403 plus 1498)(Line 14 above) |
0 |
0 |
0 |
|
|
3701 |
.................................... |
.................................... |
.................................... |
||
|
3702 |
.................................... |
.................................... |
.................................... |
||
|
3703 |
.................................... |
.................................... |
.................................... |
||
|
3798. |
Summary of remaining write-ins for Line 37 from overflow page |
.................................0 |
.................................0 |
.................................0 |
|
|
3799. |
Totals (Lines 3701 through 3703 plus 3798)(Line 37 above) |
0 |
0 |
0 |
4
STATEMENT AS OF
CASH FLOW
Cash from Operations
1
Current Year
To Date
2
Prior Year
To Date
3
Prior Year Ended
|
1. |
Premiums collected net of reinsurance |
................... 7,589,981 |
................... 5,937,653 |
................. 19,283,029 |
|
|
2. |
Net investment income |
...................... 235,142 |
...................... 228,803 |
.......................823,617 |
|
|
3. |
Miscellaneous income |
(285) |
(1,562) |
10,509 |
|
|
4. |
Total (Lines 1 to 3) |
7,824,838 |
6,164,894 |
20,117,155 |
|
|
5. |
Benefit and loss related payments |
................... 4,207,611 |
...................4,905,458 |
................. 10,044,262 |
|
|
6. |
.................Net transfers to Separate Accounts, Segregated Accounts and Protected Cell Accounts |
.................................0 |
.................................0 |
.................................0 |
|
|
7. |
...............................................Commissions, expenses paid and aggregate write-ins for deductions |
................... 1,936,769 |
................... 1,581,732 |
................... 5,934,490 |
|
|
8. |
Dividends paid to policyholders |
........................ 31,255 |
........................ 55,993 |
.......................147,639 |
|
|
9. |
Federal and foreign income taxes paid (recovered) net of $ |
tax on capital |
|||
|
gains (losses) |
0 |
0 |
(249,328) |
||
|
10. |
Total (Lines 5 through 9) |
6,175,635 |
6,543,183 |
15,877,063 |
|
|
11. |
Net cash from operations (Line 4 minus Line 10) |
1,649,203 |
(378,289) |
4,240,092 |
|
Cash from Investments
12. Proceeds from investments sold, matured or repaid:
|
12.1 |
Bonds |
...................... 640,464 |
.......................563,997 |
................... 3,287,767 |
|
|
12.2 |
Stocks |
.................................0 |
.................................0 |
.................................0 |
|
|
12.3 |
Mortgage loans |
.................................0 |
.................................0 |
.................................0 |
|
|
12.4 |
Real estate |
.................................0 |
.................................0 |
.................................0 |
|
|
12.5 |
Other invested assets |
.................................0 |
.................................0 |
.................................0 |
|
|
12.6 |
Net gains or (losses) on cash, cash equivalents and short-term investments |
.................................0 |
.................................0 |
.................................0 |
|
|
12.7 |
Miscellaneous proceeds |
30,000 |
230,000 |
200,000 |
|
|
12.8 Total investment proceeds (Lines 12.1 to 12.7) |
...................... 670,464 |
.......................793,997 |
................... 3,487,767 |
||
|
13. |
Cost of investments acquired (long-term only): |
||||
|
13.1 |
Bonds |
................... 1,505,389 |
.......................445,353 |
................... 5,375,741 |
|
|
13.2 |
Stocks |
.................................0 |
.................................0 |
.................................0 |
|
|
13.3 |
Mortgage loans |
.................................0 |
.................................0 |
.................................0 |
|
|
13.4 |
Real estate |
.................................0 |
.................................0 |
.................................0 |
|
|
13.5 |
Other invested assets |
.................................0 |
.................................0 |
.................................0 |
|
|
13.6 |
Miscellaneous applications |
0 |
0 |
0 |
|
|
13.7 |
Total investments acquired (Lines 13.1 to 13.6) |
1,505,389 |
445,353 |
5,375,741 |
|
|
14. |
Net increase (or decrease) in contract loans and premium notes |
0 |
0 |
0 |
|
|
15. |
Net cash from investments (Line 12.8 minus Line 13.7 and Line 14) |
(834,925) |
348,644 |
(1,887,974) |
|
|
Cash from Financing and Miscellaneous Sources |
|||||
|
16. |
Cash provided (applied): |
||||
|
16.1 |
Surplus notes, capital notes |
||||
|
.................................0 |
.................................0 |
.................................0 |
|||
|
16.2 |
Capital and paid in surplus, less treasury stock |
.................................0 |
.................................0 |
.................................0 |
|
|
16.3 |
Borrowed funds |
.................................0 |
.................................0 |
.................................0 |
|
|
16.4 |
Net deposits on deposit-type contracts and other insurance liabilities |
.................................0 |
.................................0 |
.................................0 |
|
|
..........................................................................................................16.5 Dividends to stockholders |
.................................0 |
.................................0 |
................... 1,704,898 |
||
|
....................................................................................................16.6 Other cash provided (applied) |
(1,751,184) |
497,177 |
(3,055,999) |
||
|
17. |
Net cash from financing and miscellaneous sources (Line 16.1 through Line 16.4 minus Line 16.5 |
||||
|
plus Line 16.6) |
(1,751,184) |
497,177 |
(4,760,897) |
||
|
RECONCILIATION OF CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS |
|||||
|
18. |
.Net change in cash, cash equivalents and short-term investments (Line 11, plus Lines 15 and 17) |
.....................(936,906) |
.......................467,532 |
................. (2,408,779) |
|
|
19. |
Cash, cash equivalents and short-term investments: |
||||
|
19.1 |
Beginning of year |
...................1,066,912 |
................... 3,475,690 |
................... 3,475,690 |
|
|
19.2 End of period (Line 18 plus Line 19.1) |
130,006 |
3,943,222 |
1,066,912 |
Note: Supplemental disclosures of cash flow information for non-cash transactions:
5
STATEMENT AS OF
NOTES TO FINANCIAL STATEMENTS
NOTE 1 Summary of Significant Accounting Policies and Going Concern
- Accounting Practices
The accompanying financial statements of the Company have been prepared on the basis of accounting practices prescribed or permitted by theInsurance Department of the Commonwealth of Pennsylvania (the "Insurance Department ").The Insurance Department requires insurance companies domiciled inPennsylvania to prepare their financial statements in accordance with theNational Association of Insurance Commissioners' ("NAIC") Annual Statement Instructions and Accounting Practices and Procedures Manual (collectively, "NAIC SAP").
The Pennsylvania Insurance Commissioner has the right to permit accounting practices that deviate from NAIC SAP. The Company did not have any permitted practices in 2024 or 2023.
NET INCOME
- State basis (Page 4, Line 20, Columns 1 & 3)
- State Prescribed Practices that are an increase/ (decrease) from NAIC SAP:
|
F/S |
F/S |
|||||||||
|
SSAP # |
Page |
Line # |
|
|
||||||
|
XXX |
XXX |
XXX |
$ |
(314,077) |
$ |
(2,437,505) |
- State Permitted Practices that are an increase/(decrease) from NAIC SAP:
|
(4) |
NAIC SAP (1-2-3=4) |
XXX |
XXX |
XXX |
$ |
(314,077) |
$ |
(2,437,505) |
|
SURPLUS |
||||||||
|
(5) |
State basis (Page 3, Line 37, Columns 1 & 2) |
XXX |
XXX |
XXX |
$ |
12,489,174 |
$ |
12,790,453 |
- State Prescribed Practices that are an increase/(decrease) from NAIC SAP:
- State Permitted Practices that are an increase/(decrease) from NAIC SAP:
|
(8) NAIC SAP (5-6-7=8) |
XXX |
XXX |
XXX |
$ |
12,489,174 |
$ |
12,790,453 |
The term "NONE" or "NOT APPLICABLE" is used in the following notes to indicate that the Company does not have any items requiring disclosure under the respective note.
- Use of Estimates in the Preparation of the Financial Statements
The preparation of the Company's statutory financial statements in conformity with accounting practices prescribed or permitted by theInsurance Department requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities. It also requires disclosure of contingent assets and liabilities at the date of the statutory financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from those estimates. - Accounting Policies
-
- Basis for Bonds and Amortization Method
Bonds not backed by other loans are stated at amortized cost or at the lower of amortized cost or fair value, if rated NAIC 3 or below, in accordance with SSAP No. 26R - Bonds,Excluding Loan-Backed and Structured Securities . Premiums and discounts on bonds are amortized or accreted, respectively, over the life of the related debt security as an adjustment to yield using the scientific method. Interest income is recognized when earned.
- Basis for Bonds and Amortization Method
-
- Basis for
Loan-Backed Securities and Adjustment Methodology
The Company reports loan-backed securities at amortized cost provided that the SVO's designation is 1 or 2. If the SVO's designation is 3 or greater, the Company reports the securities at the lower of amortized cost or fair value. The Company uses the prospective method to make valuation adjustments when necessary.
- Basis for
- Going Concern
Management has concluded that there is no doubt regarding the Company's ability to continue as a going conceas ofMarch 31, 2024 .
NOTE 2 Accounting Changes and Corrections of Errors
NONE
NOTE 3 Business Combinations and
NONE
NOTE 4 Discontinued Operations
NONE
6
STATEMENT AS OF
NOTES TO FINANCIAL STATEMENTS
NOTE 5 Investments
- Mortgage Loans, including Mezzanine Real Estate Loans
NONE - Debt Restructuring
NONE - Reverse Mortgages
NONE - Loan-BackedSecurities
-
- Description of Sources Used to Determine Prepayment Assumptions
Prepayment assumptions for single-class and multi-classmortgage-backed securities were obtained from broker dealer survey values or internal estimates. - Other-ThanTemporary Impairments
NONE Recognized OTTI Securities
NONE- All impaired securities (fair value is less than cost or amortized cost) for which an other-than-temporary impairment has not been recognized in earnings as a realized loss (including securities with a recognized other-than-temporary impairment for non-interest related declines when a non-recognized interest related impairment remains):
- Description of Sources Used to Determine Prepayment Assumptions
a) The aggregate amount of unrealized losses:
|
1. |
Less than 12 Months |
$ |
(25,421) |
|
2. |
12 Months or Longer |
$ |
(2,282,591) |
b)The aggregate related fair value of securities with unrealized losses:
|
1. |
Less than 12 Months |
$ |
2,326,299 |
|
2. |
12 Months or Longer |
$ |
20,144,475 |
-
- Information Investor Considered in Reaching Conclusion that Impairments are Not Other-Than-Temporary
The Company used pricing services in determining the fair value of its loan-backed securities. In determining that a security is not other-than-temporarily impaired, securities are analyzed for future cash flows by using current and expected losses, historical and expected prepayment speeds (based on Bloomberg and broker dealer survey values), and assumptions about recoveries relative to the seniority or subordination in the capital structure. If the results indicate that we will be able to maintain the current book yield, no other-than-temporary impairment is warranted.
- Information Investor Considered in Reaching Conclusion that Impairments are Not Other-Than-Temporary
- Dollar Repurchase Agreements and/or Securities Lending Transactions
NONE - Repurchase Agreements Transactions Accounted for as Secured Borrowing
NONE - Reverse Repurchase Agreements Transactions Accounted for as Secured Borrowing
NONE - Repurchase Agreements Transactions Accounted for as a Sale
NONE - Reverse Repurchase Agreements Transactions Accounted for as a Sale
NONE - Real Estate
NONE Low Income Housing tax Credits (LIHTC)
NONE- Restricted Assets
NO SIGNIFICANT CHANGES - Working Capital Finance Investments
NONE
6.1
STATEMENT AS OF
NOTES TO FINANCIAL STATEMENTS
- Offsetting and Netting of Assets and Liabilities
NONE - 5GI Securities
NONE Short Sales
NONE- Prepayment Penalty and Acceleration Fees
NONE - Reporting Entity's Share of
Cash Pool by Asset Type
NOT APPLICABLE
NOTE 6 Joint Ventures, Partnerships and Limited Liability Companies
NONE
NOTE 7 Investment Income
NONE
NOTE 8 Derivative Instruments
NONE
NOTE 9 Income Taxes
- Inflation Reduction Act - Corporate Alternative Minimum Tax (CAMT)
-
- The Act was enacted on
August 16, 2022 . - The controlled group of corporations of which the reporting entity is a member has determined that it does not expect to be liable for CAMT in 2024.
- Based upon projected adjusted financial statement income for 2024, the controlled group of corporations of which the reporting entity is a member has determined that average "adjusted financial statement income" is below the thresholds for the 2024 tax year such that it does not expect to be required to perform the CAMT calculations.
- The Act was enacted on
NOTE 10 Information Concerning Parent, Subsidiaries, Affiliates and Other Related Parties
- Nature of the Relationship Involved
Effective
- Material Management or Service Contracts and Cost-Sharing Arrangements
The Company participates in an Expense Allocation Agreement and a Management Services Agreement (the Agreements) with affiliates under which expenses are allocated in accordance with SSAP No. 70 - Allocation of Expenses. For the three months endedMarch 31, 2024 , EIHI was charged$544,612 under the Management Services Agreement. No management fees were charged directly to the Company.
The Company amended its Management Services Agreement to modify allocation percentages effectiveJanuary 1, 2023 . Regulatory approval or non-disapproval was received.
NOTE 11 Debt
NONE
NOTE 12 Retirement Plans, Deferred Compensation, Postemployment Benefits and Compensated Absences and Other
Postretirement Benefit Plans
NONE
NOTE 13 Capital and Surplus, Dividend Restrictions and Quasi-Reorganizations
The maximum dividend payout available to shareholders available to be paid in 2024 without prior approval of the
NOTE 14 Liabilities, Contingencies and Assessments
NO SIGNIFICANT CHANGES
NOTE 15 Leases
NONE
6.2
Attachments
Disclaimer



"ProAssurance Specialty Insurance Company","PNC AS","2024 03 31" Annual Statutory Statement
"Allied EasteIndemnity Company","PNC AS","2024 03 31" Annual Statutory Statement
Advisor News
- Why you should discuss insurance with HNW clients
- Trump announces health care plan outline
- House passes bill restricting ESG investments in retirement accounts
- How pre-retirees are approaching AI and tech
- Todd Buchanan named president of AmeriLife Wealth
More Advisor NewsAnnuity News
- Great-West Life & Annuity Insurance Company Trademark Application for “EMPOWER READY SELECT” Filed: Great-West Life & Annuity Insurance Company
- Retirees drive demand for pension-like income amid $4T savings gap
- Reframing lifetime income as an essential part of retirement planning
- Integrity adds further scale with blockbuster acquisition of AIMCOR
- MetLife Declares First Quarter 2026 Common Stock Dividend
More Annuity NewsHealth/Employee Benefits News
- Congress takes up health care again – and impatient voters shouldn't hold their breath for a cure
- U.S. Rep. Fitzpatrick pushed a health care subsidy extension. Here's what voters in his Bucks County swing district think
- Healey unveils health insurance reforms
- Researchers from University of Toronto Provide Details of New Studies and Findings in the Area of Health and Medicine (Role of Chronic Conditions in Out-of-Pocket Costs for Preventive Care in the US): Health and Medicine
- Researchers at University of Florida Target Mental Health Diseases and Conditions (Impact Of Housing Support Services For Medicaid Enrollees With Serious Mental Illness, Substance Use Disorder): Mental Health Diseases and Conditions
More Health/Employee Benefits NewsLife Insurance News